0001209191-12-040318.txt : 20120803 0001209191-12-040318.hdr.sgml : 20120803 20120803193028 ACCESSION NUMBER: 0001209191-12-040318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120801 FILED AS OF DATE: 20120803 DATE AS OF CHANGE: 20120803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIERENGA WENDALL CENTRAL INDEX KEY: 0001235945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 121008107 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL STREET 2: C/O NEUROCRINE BIOSCIENCES CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER NAME: FORMER CONFORMED NAME: WIERENGA WENDALL D DATE OF NAME CHANGE: 20030527 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-08-01 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235945 WIERENGA WENDALL C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2012-08-01 4 S 0 250 74.7605 D 9580 D Shares sold pursuant to a 10b5-1 plan. /s/ Matthew K. Fust, Attorney-in-Fact 2012-08-03